Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Proven vaccine technologies, applicable for large scale manufacturing, for rapid response against novel coronavirus, 2019-nCoV

Date added: 23 Apr 2020

The objective of this Call for Proposals is to rapidly develop and manufacture a proven vaccine approach that can be used against the 2019-nCoV.

Agency or Funder
Norwegian Coalition for Epidemic Preparedness Innovations
Eligibility (if available)

Non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and academic institutions. Hold a vaccine technology that has already been proven. Propose only one 2019-nCoV vaccine candidate per application. Have the capacity to start vaccine manufacturing in at short notice. Be an organization that must be willing to transfer their vaccine technology to a global network
of large-scale manufacturers and ideally has its own large-scale manufacturing capabilities

Foreign participation? (where known)
Yes
Date application deadline

Special Call on Coronaviruses

Date added: 23 Apr 2020

Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.

Amount
CHF 5M
Agency or Funder
Swiss Nation Science Foundation
Foreign participation? (where known)
Yes
Date application deadline

IMI2 - Call 21

Date added: 23 Apr 2020

Development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak; therapeutics to address the current and/or future coronavirus outbreaks; diagnostics, ensuring rapid evaluation of candi

Amount
€45M
Agency or Funder
IMI
Eligibility (if available)

See funding call for eligibility rules

Date application deadline

EIT calls for innovative proposals to address COVID-19

Date added: 23 Apr 2020

The EIT partnership is looking to make an immediate response to the COVID-19 pandemic. (Topics such as vaccine and drug discovery/development will not be funded.)

Amount
€600,000
Agency or Funder
EIT Health
Eligibility (if available)

Projects led by EIT Health Core or Associate Partner, in a consortium with at least two partners

Foreign participation? (where known)
Yes
Date application deadline

Short-term solutions for the COVID-19 emergency in Paraguay

Date added: 11 May 2020

Funding for public and private research into COVID-19 in the areas of epidemiological studies, diagnostics, therapeutics, behavioural science, mental health, and the development of medical and ICT devices.

Amount
PYG 300M to PYG 1B, up to 90% of project costs
Agency or Funder
Consejo Nacional de Ciencia y Tecnología, Paraguay
Eligibility (if available)

Universities, NGOs, private and public sector organisations

Date application deadline

Transatlantic call for new coronavirus treatment proposals

Date added: 05 May 2020

A call for novel therapies, broad-spectrum antivirals, next-generation vaccines that may target new corona strains, multiple corona viruses or more than one type of virus, and strategies for first responders and emergency medical personnel.

Amount
$150.000 (U.S.) guaranteed, with the potential to receive up to $1 million
Agency or Funder
Harrington Discovery Institute
Eligibility (if available)

Project lead must have an MD, PhD or equivalent and based in the U.S., UK or Canada. 

Foreign participation? (where known)
Yes
Date application deadline

Equipment for animal-free research in UK universities

Date added: 08 May 2020

Diagnostic tests, disease development, and drug identification/testing tools will be granted for immediate COVID-19 related research.

Amount
Quasi Vivo Systems, and £500 consumables budget
Agency or Funder
Animal Free Research UK and Kirkstall Ltd
Eligibility (if available)

Research must take place at a UK institution

Foreign participation? (where known)
No
Date application deadline

Funding support for clinical trials

Date added: 05 May 2020

Funding for clinical trials to evaluate new drugs, devices, clinical guidance, approaches and technologies aimed at stopping the spread of COVID-19. Projects may range from proof-of-concept to large-scale trials.

Amount
$30M (U.S.)
Agency or Funder
US Army Medical Research Acquisition Activity
Eligibility (if available)

Principal investigator must be at level of Assistant Professor or equivalent.

Foreign participation? (where known)
Yes
Date application deadline

Call for funding to research COVID-19

Date added: 23 Apr 2020

The biology of the virus and its transmission, animal and environmental research on the origin of the virus, including control measures at the human-animal interface, epidemiological studies, clinical characterization and clinical management, infe

Amount
€10M
Agency or Funder
Federal Ministry of Education and Research
Eligibility (if available)

Must comply with uniform standards for quality assurance of biomaterial banks, patient registers,
IT networking, animal studies, including ARRIVE guidelines

Foreign participation? (where known)
No
Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline